Regulatory trends in engineering bioactive-phytocompounds
Monica Saifi1, Kudsiya Ashrafi1, Firdaus Qamar1
1Centre for Transgenic Plant Development, Department of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard, Hamdard Nagar, New Delhi 110062, India.
Summary
Secondary plant metabolites are crucial for medicine and industry but scarce in plants. Molecular approaches offer scalable production, enabling new products from academic research.
Area of Science:
- Plant biochemistry and molecular biology
- Metabolomics and natural product chemistry
- Biotechnology and bioprocess engineering
Background:
- Secondary plant metabolites possess significant medicinal, nutraceutical, and industrial value.
- Limited quantities of these compounds in plants pose challenges for large-scale applications.
- Increasing demand necessitates efficient and sustainable production methods.
Purpose of the Study:
- To review emerging regulatory trends in engineering bioactive phytocompounds.
- To provide recommendations for translating academic research into industrial processes and products.
- To highlight state-of-the-art molecular approaches for scalable metabolite production.
Main Methods:
- Discussion of molecular strategies for enhancing phytocompound production.
- Analysis of regulatory landscapes for biotechnological applications.
- Review of case studies on metabolite engineering and production.
Main Results:
- Identification of key regulatory hurdles and opportunities in metabolite engineering.
- Outlined strategies for optimizing scalable production of valuable plant compounds.
- Demonstrated potential for novel product development through advanced biotechnologies.
Conclusions:
- Molecular engineering offers a viable solution for sustainable production of plant secondary metabolites.
- Navigating regulatory trends is crucial for successful commercialization of engineered phytocompounds.
- Interdisciplinary approaches are essential for translating research into impactful industrial applications.
Related Concept Videos
Regulation of Metabolism
9.4K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.4K
Structure-Activity Relationships and Drug Design
697
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
697
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Control Governance: Regulatory Bodies and Their Impact
150
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
150
Pharmacovigilance
817
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
817
Effects of Chemicals: Overview
1.2K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.2K


